REFERENCES
- Munnich A, Rotig A, Cormier-Daire V, Rustin P. Clinical presentation of respiratory chain deficiency. In: Scriver CR, Beaudet AL, Sly SW, et al., eds. The Metabolic & Molecular Bases of Inherited Diseases, 8th ed. New York:McGraw-Hill Medical; 2001:2261–2274.
- Fosslien E. Mitichondrial medicine: molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci. 2001;31:25–67.
- DiMauro S, Bonilla E. Mitochondrial encephalomyopathy. In: Engel AG, Franzini-Amstrong C, eds, Myology, 3rd ed. McGraw-Hill, NY, 2004;1623–1662.
- Vogel H. Mitochondrial myopathies and the role of pathologist in the molecular era. J Neuropathol Exp Neurol. 2001;60:217–227.
- Taylor RW Schaefer AM, Barron MJ, et al. The diagnosis of mitochondrial disease. Neruromusc Disord. 2004;14:237–245.
- Lloreta-Trull J, Serrano S. Biology and pathology of the mitochondrion. Ultrastruct Pathol. 1998;22:357–367.
- Shoffner JM. Oxidative phosphorelation disease. Clinical presentation of respiratory chain deficiency. In: Scriver CR, Beaudet AL, Sly SW, et al., eds. The Metabolic & Molecular Bases of Inherited Diseases, 8th ed. New York:McGraw-Hill Medical; 2001:2367–2423.
- Wallace DC, Lott MT, Brown MD, Kerstann K. Mitochondria and neuro-ophthalmic diseases. In: Scriver CR, Beaudet AL, Sly SW, et al., eds. The Metabolic & Molecular Bases of Inherited Diseases, 8th ed. New York:McGraw-Hill Medical; 2001:2425–2509.
- Wabbels B, Ali N, Kunz WS, et al. Chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome: interdisciplinary diagnosis and therapy. Ophthalmologe. 2008;105:550–556.
- Cardaioli E, Da Pozzo P, Malfatti E, et al. Chronic progressive external ophthalmoplegia: a new heteroplsmic tRNALeu(CUN) mutation of mitochondrial 11. DNA. J Neurosci. 2008;272:106–109.
- Reichmann H, Gold R, Meurers B, et al. Progression of myopathology in Kearns-Sayre syndrome: a morphological follow-up study. Acta Neuropathol. 1993;85:679–681.
- Hass R H, Parikh S, Falk MJ, et al. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab. 2008;94:16–37.
- Charles R, Holt S, Kay JM, et al. Myocardial ultrastructure and the development of artioventricular block in Kearns-Sayre syndrome. Circulation. 1981;60:214–219.
- Wredenberg A, Wibom R, Wilhelmsson H, et al. Increased mitochondrial mass in mitochondrial myopathy mice. Proc Natl Acad Sci USA. 2002;99:15066–15071.
- Chang TS, Johns DR, Walker D, et al. Ocular clinicopathologic study of mitochondrial encephalomyopathy overlap syndromes. Arch Ophthalmol. 1993;111:1254–1262.
- Lindal S, Lund I, Torbergsen T, et al. Mitochondrial diseases and myopathies: a series of muscle biopsy speciemens with ultrastructural changes in the mitochondria. Ultrastruct Pathol. 1992;16:263–275.
- Scaglia F, Towbin JA, Craigen WJ, et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics. 2004;114:925–931.
- Carta A, D'Adda T, Carrara F, Zeviani M. Ultrastructural analysis of extraocular muscle in chronic progressive external ophthalmoplegia. Arch Ophthalmol. 2000;118:1441–1445.
- Schwartzkopff B, Frenzel H, Breithardt G, et al. Ultrastructural findings in endomyocardial biopsy of patients with Kearns-Sayre syndrome. J Am Coll Cardiol. 1988;12:1522–1528.
- Kyriancou K, Milkellidou C, Hadjianastasio A, et al. Ultrastructural diagnosis of mitochondrial encephalopathies revisited. Ultrastruct Pathol. 1999;23:163–170.
- Bril V, Rewcastle NB, Humphrey J. Oculoskeletal myopathy with abnormal mitochondria. Can J Neurol Sci. 1984;11:390–394.